Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Agilon Health ( (AGL) ) just unveiled an update.
On April 24, 2026, agilon health appointed healthcare veteran Tim O’Rourke as its next Chief Executive Officer and President, effective May 7, 2026, and named him to the board as a Class III director. He succeeds Executive Chairman Ronald A. Williams, who has been leading the company’s transformation and will remain as Chairman of the Board, marking a planned transition from an executive-led restructuring phase to a new growth-focused leadership structure.
O’Rourke, 54, brings more than 25 years of experience spanning payors and providers, including senior roles at Humana, Centene and most recently as President of Help at Home, where he oversaw a large national in-home care operation serving complex Medicare and Medicaid patients. His compensation package includes an $850,000 base salary, a target annual bonus equal to his base salary, a $500,000 signing bonus and substantial equity awards of time-based and performance-based restricted stock units tied to ambitious long-term share price targets, aligning his incentives with shareholder value and the company’s strategic push in value-based senior care.
The performance-based stock units will vest in three tranches over a three-year period only if agilon’s stock sustains weighted average prices of at least $50, $100 and $150 for 30 consecutive trading days, while time-based units vest over three years of continued employment. In the event of termination without cause or resignation for good reason, O’Rourke will receive 18 months of salary, a target-level bonus, continued medical coverage and partial acceleration of unvested equity, with enhanced treatment following a change in control, signaling the board’s desire to secure stable leadership during a critical strategic phase.
Agilon’s board highlighted that O’Rourke’s track record in Medicare Advantage, value-based care and provider-integrated plans positions him to build on the company’s recent operational and financial overhaul. Company leaders emphasized that the appointment caps a comprehensive CEO search and is intended to leverage the strengthened foundation in data, analytics, contracting discipline and cost management, with the goal of driving sustainable growth and creating long-term value for physicians, patients, payors and shareholders.
The most recent analyst rating on (AGL) stock is a Hold with a $17.00 price target. To see the full list of analyst forecasts on Agilon Health stock, see the AGL Stock Forecast page.
Spark’s Take on AGL Stock
According to Spark, TipRanks’ AI Analyst, AGL is a Neutral.
The score is held back primarily by weak financial performance—ongoing losses, sustained cash burn, and a reduced equity cushion. Technicals are supportive with strong momentum above major moving averages, but overbought indicators raise near-term risk. The latest guidance supports a potential 2026 stabilization toward breakeven, though execution and medical-cost/regulatory uncertainty remain significant.
To see Spark’s full report on AGL stock, click here.
More about Agilon Health
Agilon health, based in Westerville, Ohio, operates in the healthcare services industry as a value-based care platform focused on senior patients. The company partners with physician groups and health systems in roughly 30 U.S. communities, providing technology, capital, operational support and a peer network to help primary care physicians transition to and manage total-care, risk-based models for Medicare and other senior populations.
Through its purpose-built platform and Total Care Model, agilon health positions itself as a key intermediary between payors and providers, emphasizing physician independence and outcomes-based reimbursement. By empowering approximately 2,300 primary care physicians with data analytics, contracting expertise and population health tools, the company aims to deliver higher-quality care for vulnerable seniors while benefiting from the long-term demand for value-based, physician-led healthcare arrangements.
Average Trading Volume: 322,417
Technical Sentiment Signal: Sell
Current Market Cap: $435.2M
Learn more about AGL stock on TipRanks’ Stock Analysis page.